SUPERNUS PHARMACEUTICALS, INC.

CIK 1356576 · 1,217 filings in 47 form types · 2006-03-06 to 2026-11-12 · SUPN

Former names: SUPERNUS PHARMACEUTICALS INC

FiledFormCategory8-K items / descriptionAccession
2026-11-12 15-12G Other 0001104659-26-125525
2026-11-04 4 Ownership 0002117599-26-000009
2026-11-04 4 Ownership 0001899935-26-000009
2026-11-04 4 Ownership 0001836067-26-000014
2026-11-04 4 Ownership 0001804567-26-000018
2026-11-04 4 Ownership 0001745316-26-000006
2026-11-04 4 Ownership 0001539937-26-000016
2026-11-04 4 Ownership 0001539215-26-000014
2026-11-04 4 Ownership 0001438462-26-000008
2026-11-04 4 Ownership 0001256088-26-000008
2026-11-04 4 Ownership 0001194020-26-000019
2026-11-04 4 Ownership 0001005544-26-000006
2026-11-02 4 Ownership 0002117599-26-000006
2026-11-02 4 Ownership 0001836067-26-000012
2026-11-02 4 Ownership 0001804567-26-000016
2026-11-02 4 Ownership 0001628280-26-068881
2026-11-02 4 Ownership 0001539937-26-000014
2026-11-02 25-NSE Other 0001354457-26-001045
2026-11-02 4 Ownership 0001194020-26-000017
2026-11-02 8-K Current reports 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 0001104659-26-121103
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121040
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121039
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121038
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121035
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121034
2026-11-02 S-8 POS Registrations and prospectuses 0001104659-26-121032
2026-11-02 8-K Current reports 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.03 Material Modification to Rights of Security Holders; 5.01 Changes in Control of Registrant; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits 0001104659-26-121014
2026-10-29 10-Q Financial reports 10-Q 0001356576-26-000051
2026-10-29 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001356576-26-000050
2026-10-26 8-K Current reports 1.02 Termination of a Material Definitive Agreement; 9.01 Financial Statements and Exhibits 0001356576-26-000045
2026-10-22 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-26-117937
2026-10-19 8-K Current reports 2.02 Results of Operations and Financial Condition 0001356576-26-000043
2026-10-15 8-K Current reports 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits 0001356576-26-000040
2026-10-06 425 Registrations and prospectuses 0001104659-26-113884
2026-10-06 DEFA14A Proxies 0001104659-26-113882
2026-09-11 DEFM14A Proxies 0001104659-26-107109
2026-08-14 4 Ownership 0001836067-26-000010
2026-08-14 4 Ownership 0001804567-26-000014
2026-08-14 4 Ownership 0001539937-26-000012
2026-08-14 4 Ownership 0001539215-26-000012
2026-08-14 4 Ownership 0001194020-26-000015
2026-08-06 SCHEDULE 13G/A Ownership 0001104659-26-092198
2026-08-04 425 Registrations and prospectuses 0001193125-26-331036
2026-08-03 10-Q Financial reports 10-Q 0001356576-26-000037
2026-08-03 8-K Current reports 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits 0001356576-26-000035
2026-08-03 425 Registrations and prospectuses 0001193125-26-330875
2026-08-03 DEFA14A Proxies 0001104659-26-089849
2026-08-03 425 Registrations and prospectuses 0001104659-26-089848
2026-08-03 8-K Current reports 8.01 Other Events; 9.01 Financial Statements and Exhibits 0001104659-26-089839
2026-08-03 DEFA14A Proxies 0001104659-26-089526